Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?
@article{TLCR41489, author = {Hiroaki Kanemura and Masayuki Takeda and Kazuhiko Nakagawa}, title = {Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?}, journal = {Translational Lung Cancer Research}, volume = {9}, number = {4}, year = {2020}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/41489} }